Repository logo
 
Publication

A new bioactive dermal substitute for wound healing and skin regeneration

2026-05-01Conference object Open access
Simple item page
dc.contributor.authorRosadas, Marta
dc.contributor.authorSousa, Teresa
dc.contributor.authorReis, Mariana
dc.contributor.authorSousa, Clara
dc.contributor.authorSousa, Alda
dc.contributor.authorSánchez Espinel, Christian
dc.contributor.authorPeleteiro, Mercedes
dc.contributor.authorGonzález-Fernández, África
dc.contributor.authorRibeiro, Viviana P.
dc.contributor.authorOliveira, Ana Leite
dc.date.accessioned2026-01-15T11:51:46Z
dc.date.available2026-01-15T11:51:46Z
dc.date.issued2026-05-01
dc.description.abstractAim: Rabbit skin is an abundant agri-food by-product with interesting properties to be up-cycled into a xenogeneic dermal substrate for skin and regeneration. When decellularized, rabbit dermis preserves collagen–elastin components that can guide cell behavior. However, decellularization conditions can also influence the preservation of tissue architecture and may introduce immunogenic triggers such as damage-associated molecular patterns (DAMPs). This work aimed to develop low-immunogenicity decellularized dermal matrices (dDMs) using rabbit skin as by- product. Method: dDMs were generated using optimized chemical decellularization protocols and evaluated for structural and biochemical integrity using SEM, tensile testing, FTIR, proteomics, and DNA, GAGs, collagen, and elastin quantification. Immunogenicity was assessed throughendotoxin analysis and by exposing human peripheral blood mononuclear cells (PBMCs) to the matrices to measure complement activation, ROS, apoptosis, activation markers, and cytokine release. The ability of dDMs to support human dermal fibroblasts (hDFs) and keratinocytes (HaCaTs) was examined over 14 days using Alamar Blue, BrdU, SEM, and DAPI/phalloidin staining. Results/Discussion: dRDMs preserved native collagen–elastin architecture, and GAG levels were comparable to human dermis. Residual DNA confirmed effective decellularization. No significant immune activation occurred: ROS and apoptosis were absent, and PBMC activation matched controls with only mild monocyte and B-cell responses. Cytokine release indicated modest inflammatory signaling induction. Interestingly, matrices with lower DNA content triggered stronger immune responses, suggesting biocompatibility is influenced more by processing-related factors (detergent residues or DAMPs) than by DNA levels. hDF and HaCaT adhesion, viability, and proliferation were maintained for 14 days. Conclusion: dRDMs showed favorable structural, biochemical, and immunological profiles and supported dermo-epidermal cell growth, demonstrating potential as bioactive dermal substitutes for skin regeneration.eng
dc.identifier.citationRosadas, M., Sousa, T., Reis, M., & Sousa, C. et al. (2026). A new bioactive dermal substitute for wound healing and skin regeneration. Abstract from 36th Conference of the European Wound Management Association, Bremen, Bremen, Germany.
dc.identifier.other63dfc0ed-55a8-4d9b-9601-2599919fbccf
dc.identifier.urihttp://hdl.handle.net/10400.14/56570
dc.language.isoeng
dc.peerreviewedyes
dc.rights.uriN/A
dc.titleA new bioactive dermal substitute for wound healing and skin regenerationeng
dc.typeconference object
dspace.entity.typePublication
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
137975521.pdf
Size:
163.69 KB
Format:
Adobe Portable Document Format
Download

Collections

CBQF - Documentos de Conferências / Conference Objects